With verdicts in medical liability lawsuits reaching the tens of millions of dollars, health-care providers should be aware of how the cards are stacked should they ever be brought to trial. The good news is that defendants win in more than 62% of all medical malpractice cases, Harvard Law School's Linda Crawford, JD, told Medical Liability Monitor (12/03). That's a better rate than any other type of tort, she added.
With that in mind, Crawford notes that, these days, jurors base their decisions on issues of character before conduct. She said that jurors first try to determine who they can trustand the physician defendant who testifies on his own behalf tops the list of the trustworthy, above the plaintiff, the attorneys, and the expert witnesses.
Crawford added that jurors also consider the physician defendant's competency, placing more weight on experience and good judgment than academic credentials. They then determine whether the physician did the best he could under the circumstances and if he made the right medical decision.
Meeting the test of character in the jurors' eyes can benefit a defendant's case. "Juries want providers who exhibit character, whether it is in the examining room, operating room, deposition, or courtroom," Crawford said.
Hormone therapy safety: Study finds potential benefits for senior women
April 24th 2024A recent large-scale study challenged age-related concerns, suggesting hormone therapy may offer safety and even benefits for menopausal women aged over 65 years, aligning with The Menopause Society's 2022 Position Statement.
Read More
Hyperoxygenation use not linked to neonatal outcomes
April 23rd 2024Recent research evaluated the impact of maternal hyperoxygenation on neonatal Apgar scores, revealing no significant enhancement in outcomes among women with pathologic fetal heart rate tracing and suggesting limited efficacy of hyperoxygenation therapy in this context.
Read More
Study finds antihypertensive treatment reduces uterine fibroids risk
April 23rd 2024A recent study revealed that patients with untreated or new-onset hypertension face elevated chances of uterine fibroid diagnosis, underscoring the potential of antihypertensive therapy in mitigating this risk among midlife individuals.
Read More